MOSCOW (MRC) -- Celanese (Dallas, Texas) has reported first quarter financial results and withdrawn previous annual earnings guidance, citing uncertainty around the coronavirus disease 2019 (COVID-19) pandemic, according to Chemweek.
The company also announced measures to address the financial impact of the pandemic, including the deferral of a new acetic acid plant at Clear Lake, Texas, by 18 months.
"We estimate the impact of COVID-19 on our first quarter adjusted EBIT across our businesses was USD25 to USD30 million," says Lori Ryerkerk, chairman and CEO. "The primary challenges encountered were a result of immediate actions in China in February and March to stem the spread of the virus. Demand activity was reduced several weeks beyond the typical Chinese New Year and further limited by logistics availability into March. The impact of COVID-19 on our businesses in the Western Hemisphere was very limited in the first quarter."
Net earnings for the quarter totaled USD220 million, up 388% sequentially from USD45 million, but down 35% year-over-year (YOY) from USD338 million. Sales totaled USD1.46 billion, up 1.9% sequentially from USD1.432 billion, but down 13% YOY from USD1.687 billion. Adjusted earnings per share came to USD2.29, up 15% sequentially from USD1.99, down 13% YOY from USD2.62, and ahead of the average analyst estimate of USD2.24 as compiled by Refinitiv (New York).
"We anticipate that we will generate USD300-400 million of incremental cash due specifically to the actions we are currently taking on productivity, working capital management, and capital expenditures prioritization which allow us to offset meaningful demand and earnings challenges and deliver exceptionally resilient cash flow in 2020," says Ryerkerk.
Celanese has achieved one-third of its 2020 productivity target, announced during the first quarter, of approximately USD200 million of gross savings, says Ryerkerk. "(W)e are also working on one-time cost savings of $30-40 million through travel reductions, manufacturing costs, and other corporate function expense. As part of these one-time savings, we are leveraging our manufacturing flexibility to temporarily reoptimize utilization of our global production network to align with expected demand softness in the second quarter and potentially beyond."
Celanese has paused production at certain facilities or units, mainly affecting the engineered materials segment but also the acetyl chain, and it has extended the duration of several second quarter turnarounds, including the Bishop, Texas, and Nanjing, China, facilities. The company will therefore "heavily utilize existing inventory" during the second quarter.
Celanese has also reduced its capital spending plans from previous guidance of USD500 million to less than USD350 million by prioritizing productivity-based projects with near-term benefits, says Ryerkerk. Construction of the new Clear Lake, Texas, acetic acid will be deferred by about 18 months, with completion now slated for the middle of 2023. The associated incremental expansion of the Clear Lake methanol unit will also be deferred by 18 months. The company has also decided that further localization of engineered materials production in China will proceed incrementally for the time being.
The engineered materials segment reported net sales of USD563 million, up 4% from the fourth quarter of 2019 on higher volume, but down 15% YOY. Robust growth in the Western Hemisphere offset declines in Asia tied to the COVID-19 pandemic and the Lunar New Year, although demand softened late in the quarter, says the company. Price levels held sequentially, while raw material costs declined. Adjusted EBIT totaled USD165 million, up sequentially from USD136 million and down YOY from USD183 million.
The acetyl chain reported net sales of USD799 million, up 3.6% sequentially as volume growth partially offset a continued decline in industry pricing resulting from weakness in Asian demand and lower raw material costs. Adjusted EBIT totaled USD139 million, down sequentially from USD144 million and down YOY from USD203 million. The pandemic reduced income by about USD15 million, largely through customer order cancellations in March.
Acetate tow sales totaled USD129 million, down 13% sequentially and down 22% YOY. Adjusted EBIT came to USD67 million, up sequentially from USD54 million and down YOY from USD72 million.
As MRC informed previously, Celanese Corporation, a global chemical and specialty materials company, has restarted its vinyl acetate monomer (VAM) unit in Singapore. The company has resumed operations at the unit on March 16, 2020. The unit was shut since February 4, 2020 following a fire at the site. Located in Jurong Island, Singapore, the unit has a production capacity of 210,000 mt/year.
VAM is the main feedstock for the production of ethylene-vinyl-acetate (EVA).
According to MRC's DataScope report, February EVA imports to Russia rose by 9,83% year on year to 3,107 tonnes from 2,829 tonnes a year earlier, and overall imports of this grade of ethylene copolymer into the Russian Federation increased in January-February 2020 by 8,36% year on year to 6,194 tonnes (5,716 tonnes a year earlier).
Celanese Corporation is a global technology leader in the production of differentiated chemistry solutions and specialty materials used in most major industries and consumer applications. Based in Dallas, Celanese employs approximately 7,700 employees worldwide and had 2019 net sales of USD6.3 billion.
MRC